.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Queensland Health
US Department of Justice
Johnson and Johnson
Chubb
Medtronic
Mallinckrodt
Argus Health
Harvard Business School
Merck

Generated: January 17, 2018

DrugPatentWatch Database Preview

Patents Expiring in August 2022

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-002Apr 29, 2008RXYesNo➤ Subscribe➤ SubscribeMETHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY OPENING CHLORIDE CHANNELS (CIC)
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-001Jan 31, 2006RXYesYes➤ Subscribe➤ SubscribeMETHOD FOR TREATING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED CONSTIPATION BY OPENING CIC CHANNELS
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-001Jan 31, 2006RXYesYes➤ Subscribe➤ SubscribeMETHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMALIAN SUBJECT
Sucampo Pharma LlcAMITIZAlubiprostoneCAPSULE;ORAL021908-002Apr 29, 2008RXYesNo➤ Subscribe➤ SubscribeMETHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMALIAN SUBJECT
Janssen PharmsLEVAQUINlevofloxacinSOLUTION;ORAL021721-001Oct 21, 2004DISCNYesNo➤ Subscribe➤ SubscribeY
Theravance BiopharmaVIBATIVtelavancin hydrochloridePOWDER;IV (INFUSION)022110-002Sep 11, 2009RXYesYes➤ Subscribe➤ SubscribeY
Theravance BiopharmaVIBATIVtelavancin hydrochloridePOWDER;IV (INFUSION)022110-001Sep 11, 2009DISCNYesNo➤ Subscribe➤ SubscribeY
Novo Nordisk IncXULTOPHY 100/3.6insulin degludec; liraglutideSOLUTION;SUBCUTANEOUS208583-001Nov 21, 2016RXYesYes➤ Subscribe➤ SubscribeYY
Novo Nordisk IncVICTOZAliraglutide recombinantSOLUTION;SUBCUTANEOUS022341-001Jan 25, 2010RXYesYes➤ Subscribe➤ SubscribeYYA METHOD FOR IMPROVING GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS
Novo Nordisk IncSAXENDAliraglutide recombinantSOLUTION;SUBCUTANEOUS206321-001Dec 23, 2014RXYesYes➤ Subscribe➤ SubscribeYYMETHOD FOR CHRONIC WEIGHT MANAGEMENT BY TREATING OBESITY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Cerilliant
Boehringer Ingelheim
Merck
Deloitte
Fish and Richardson
Fuji
McKesson
Accenture
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot